首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human IL23A Recombinant Antibody(Tildrakizumab)

Anti-Human IL23A Recombinant Antibody(Tildrakizumab)

产品编号

YR1295

别名

科研级 Tildrakizumab ( 替曲吉珠单抗 ), Anti-IL23A Recombinant Antibody, Research Grade Tildrakizumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Tildrakizumab ( 替曲吉珠单抗 ), Anti-IL23A Recombinant Antibody, Research Grade Tildrakizumab
Catalog NumberYR1295
Molecular NameTildrakizumab
HostMouse
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1 Kappa
FormulationPBS, pH7.5
BackgroundTildrakizumab (trade name Ilumya (US)/Ilumetri (European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. It is approved for the treatment of adult patients with moderate-to-severe plaque psoriasis in the United States and the European Union.
CAS Number1326244-10-3
ApplicationNeut, ELISA, IF, IP, FuncS, FCM, ICC
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
Molecular Weight144.4 kDa
TargetIL23A[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价